|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Securities amortization and accretion, net | |||||
| Loans originated for sale | |||||
| Proceeds from sales of loans held for sale | |||||
| Gain on sale of mortgage loans | |||||
| Loss on sale of securities | |||||
| (Reversal of) provision for credit losses | |||||
| Earnings on bank owned life insurance | |||||
| Issuance of common shares donated to North Shore Trust and Savings Charitable Foundation | |||||
| ESOP expense | |||||
| Stock based compensation expense, net of forfeitures | |||||
| Change in deferred income taxes | |||||
| Net change in accrued interest receivable and other assets | |||||
| Net change in accrued expenses and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of loans, net | |||||
| Net change in portfolio loans | |||||
| Principal repayments on mortgage-backed securities | |||||
| Purchases of securities available for sale | |||||
| Maturities and calls of securities available for sale | |||||
| Sales of securities available for sale | |||||
| Purchase of Federal Home Loan Bank stock | |||||
| Net change in time deposits with other financial institutions | |||||
| Purchases of premises and equipment, net | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net change in deposits | |||||
| Net change in escrow deposits | |||||
| Proceeds from Federal Reserve Bank - Bank Term Funding Program | |||||
| Repayment of Federal Reserve Bank - Bank Term Funding Program | |||||
| Purchase of treasury stock | |||||
| Net proceeds from issuance of common shares | |||||
| Loan to ESOP | |||||
| Purchase of treasury stock from taxes withheld on net share settlement of restricted stock awards | |||||
| Proceeds from exercise of stock options | |||||
| Net cash (used in) provided by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Loans transferred to held for sale from portfolio, net | |||||
| Cash paid during the period for: Interest | |||||
| Income taxes | |||||
Loading...